Eicosanoids derived from lipoxygenase (LO)-catalyzed reactions play important roles in pulmonary inflammation. Here, we examined formation of LO-derived products by human alveolar macrophages (HAM). HAM converted 11-4Cl-arachidonic acid to a product carrying '4C-radiolabel that was identified as 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid (15-HETE) by physical methods. 15-LO mRNA was demonstrated in HAM by reverse transcription-polymerase chain reaction. Incubation of HAM for 3 d with interleukin 4 (IL-4) before exposure to j1-"4Clarachidonic acid led to both increased mRNA for 15-LO and a 4-fold increase in 15-HETE formation. In contrast, 5(S)-hydroxy-6-trans-8,11,14-cis-eicosatetraenoic acid generation was not significantly altered by prior exposure to IL-4. Additionally, lipoxins (LXA4 and LXB4) were detected from endogenous substrate, albeit in lower levels than leukotriene B4 (LTB4), in electrochemical detection/high performance liquid chromatography profiles from HAM incubated in the presence and absence of the chemotactic peptide (FMLP) or the calcium ionophore (A23187).
Introduction
Human alveolar macrophages (HAM)' are cells that may play a major role in host defense, and conversely display significant phlogistic potential ( 1 ) Receivedforpublication 26 August 1992 and in revisedform 7 May 1993. their diverse bioactions may be mediated by the generation of eicosanoids (1) . For example, HAM exposed to a variety of stimuli in vitro can generate 5-lipoxygenase (5-LO) products including leukotriene B4 (LTB4) (2, 3), a potent chemoattractant (reviewed in reference 4) . Despite an abundance of 15(S)-hydroxy-5,8,1 1-cis-13-trans-eicosatetraenoic acid ( 1 5-HETE) in bronchoalveolar lavage (BAL) fluid and human lung (5, 6), 15 -lipoxygenase (15-LO) activity has not been documented in HAM. 1 5-HETE generation in the respiratory tract may be important since, in vitro, this eicosanoid can both regulate LT production (4) and serve as one of the substrates for conversion to lipoxins (reviewed in references 4 and 7) .
Cytokines can regulate the formation of LO-derived products. IL-4 is found in the microenvironment of HAM, especially in disease states such as asthma (8) . Moreover, macrophages possess IL-4 receptors (9) and the induction of 1 5-LO by IL-4 was recently demonstrated in human peripheral blood monocytes (10) .
Lipoxins (LX) , formed by interactions between individual lipoxygenases (reviewed in references 4 and 7), are also found in BAL fluid from patients with a variety ofrespiratory diseases ( 11) . There is growing evidence that these compounds, in submicromolar amounts, act as endogenous regulators of leukotriene (LT)-induced responses (reviewed in reference 7) . Despite potential roles for LX in the human lung ( 12) , LX production by HAM has not yet been evaluated.
Given the documented actions for both 1 5-HETE and LX in the respiratory tract (4, 13, 14) , we have examined HAM contribution to their production. Here, we report that 15-HETE is generated by HAM and that its production is enhanced by IL-4. In addition, evidence is provided for LX generation by HAM from both endogenous and exogenous substrates.
Methods
Materials. lonophore (A23187), FMLP, aspirin, and indomethacin were from Sigma Chemical Co. (St. Louis, MO). Synthetic eicosanoids were 1. Abbreviations used in this paper: AA, arachidonic acid; BAL, bronchoalveolar lavage; ED, electrochemical detection; HAM, human alveolar macrophages; 5-HETE, 5(S)-hydroxy-6-trans-8, 1 1,14-cis-eicosatetraenoic acid; 15-HETE, 15(S)-hydroxy-5,8,1 1-cis-13-trans-eicosatetraenoic acid; 13-HODE, 13-hydroxy-9-cis-1 1-trans-octadecadienoic acid; LO, lipoxygenase; LTA4 (leukotriene A4), 5(S)-trans-5,6-oxido-7,9-trans-1 1, 14-cis-eicosatetraenoic acid; LTB4(leukotriene B4), 5 (S), 12(R)-dihydroxy-6, 14-cis-8, l0-trans-dihydroxyeicosatetraenoic acid; LX, lipoxin; LXA4 (lipoxin A4), 5(S),6(R),15(S)-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid; LXB4 (lipoxin B4), 5 Incubation conditions. HAM were washed with PBS, then suspended with PBS containing 1 mM CaC12, 1 mM MgCl2, and 1.8 mM ATP, and incubated either intact or after freeze-thaw. HAM were permeabilized to increase substrate availability and LO-derived product formation by rapid freezing in a dry ice-acetone bath, thawed to room temperature (full cycle -30 min), and taken directly for incubations ( 15) . Suspensions were then exposed to arachidonic acid (AA; All incubations were terminated with iced MeOH (2 vol) containing either PGB2 or 13-hydroxy-9-cis-1 l-trans-octadecadienoic acid ( 13-HODE) as internal standards.
Isolation and RT ofRNA. HAM (2 x 106) were lysed with guanidine isothiocyanate (4 M) to extract total cellular RNA which was isolated by centrifugation through cesium chloride (5.7 M) at 100,000 g for 18 h ( 17). Because small amounts of RNA were present, transfer RNA (20 Mg) from Escherichia coli was added to each sample to serve as carrier before centrifugation. RNA pellets were resuspended in 300
Ml RNase-free water, phenol/chloroform extracted, ethanol precipitated in the presence ofNaAcetate (3M, pH 5.2), dried, resuspended in 50 ,l of RNase-free water, and quantified by the presence ofultraviolet (UV)-adsorbing material at 260 nm. This procedure was also used with RNA isolated from peripheral blood monocytes (10) . Nonsmoker lung RNA was donated by the Brigham and Women's Hospital Lung Transplantation Tissue Bank.
RNA from each volunteer was reverse transcribed as described (18) . Briefly, each sample contained 500 ng of total cellular RNA, RT buffer, 1 mM dNTPs, 0.2 Mg poly(T) antisense coding oligonucleotide primer, 40 U RNacin, 60Mgg acetylated BSA, and 400 U mmLV. After incubation at 25°C for 10 min and 42°C for 60 min, the reactions were terminated by heating to 100°C for 10 min. Samples were kept at 4°C until used. Preparation of oligonucleotide primers. Oligonucleotide primers were constructed from published cDNA sequences of 15-LO (19) and ,B-actin (20) . The primers for 15-LO were selected to minimize the considerable sequence homology between 5-, 12-, and 15-LO (21) . The primers were synthesized using a model 392 DNA/RNA synthesizer (Applied Biosystems, Inc., Foster City, CA), quantified by UV absorbance at 260 nm, and stored at 4°C. The sequence of the 15 Restriction endonucleases, Apa-I and Pst-1, were identified using the Mac Vector program (version 4.0) with unique targets in the first 300 bp ofputative 15-LO and 5-LO products, respectively. The amplified products (25 Eicosanoid analysis. LO products were extracted and quantitated as in (15, 16) . After centrifugation, samples were rapidly loaded into cartridges (C18 Sep-Paks), washed with H20, and eluted with hexane, methyl formate, and MeOH. Materials eluted from methyl formate and MeOH fractions were concentrated with N2, examined for UV-absorbing materials, and injected into a RP-HPLC system. 6-trans-LTB4, 12-epi-6-trans-LTB4, LTB4, and LX were resolved using tandem electrochemical (ED)-UV detection with RP-HPLC. This system was equipped with 11) . The first 300 bp of 15-LO DNA has an Apa-l site consistent with the observed cleavage, whereas 5-LO has only a Pst-l site (19) . Samples were electrophoresed through a 3% (wt/vol) agarose gel in TBE buffer containing ethidium bromide (0.5 ug/ml) and photographed under UV illumination.
301 nm (to monitor LX). Detection limits of the LX and LT in this system were determined to be in the picogram range; these values were consistent with those reported by Herrmann et al. (22) . Mono-HETEs were resolved using an RP-HPLC system equipped with a Lambda Max UV detector, model 481, and the column (Beckman Ultrasphere-ODS, 5 um, 4.6 mm X 25 cm) was eluted at 1 ml/ min with MeOH/H20/acetic acid (75:25:0.01, vol/vol/vol). The UV detector was set at 234 nm. Fractions (1 ml) were collected and the presence of radiolabel determined by scintillation spectrophotometry. LT and LX were identified by comparison of individual retention times with those obtained for synthetic standards in each RP-HPLC system. Their quantities were determined by comparing peak areas obtained for calibrated standards in each HPLC system with the corresponding products from individual incubations after correction for the recovery of internal standard. ED peak heights were not used for quantitation in the present experiments but ED reactivities served as an additional criterion to identify amounts ofLX, < 5 ng, present in some UV tracings. Cells obtained and viability. The mean cell number was 11.3±3.7 X 106 per bronchoscopy (mean±SD) with a viability by trypan blue exclusion of 95.6±3.2% (n = 10), which remained at 92.5±3.2% after incubations. Analysis of cell types revealed 96.1±0.7% macrophages, 3.0±0.5% lymphocytes, 0.6±0.2% neutrophils, and 0.3±0.2% eosinophils.
15-HETEformation by HAM: regulation by IL-4. Consistent with prior reports ( 1-4), HAM exposed to [1-"'C ] AA generated a product carrying the '4C-radiolabel with the retention time ofauthentic 5-HETE (Fig. 1) . In these incubations, HAM also produced material which eluted with the same retention time (21 min) as 1 5-HETE; this product carried radiolabel and coeluted with authentic 1 5-HETE (Fig. 1) .
To determine whether HAM 1 5-LO activity and 1 5-HETE generation are regulated by IL-4, as in monocytes (1O), cells were incubated in the presence or absence of IL-4. HAM were permeabilized to facilitate substrate availability before addition of [1-'4C]AA (20 min, 370C). Cells exposed to IL-4 generated four to five times more 15-HETE than cells cultured in its absence (Table I) . Increases in 15-HETE formation were also obtained with intact cells incubated with IL-4 (n = 3; data not shown). In contrast, 5-HETE production by HAM was not influenced in a statistically significant manner by IL-4 treatment ( Table I ), suggesting that IL-4 specifically upregulates 1 5-LO activity.
Identification ofHAM 15-LO. 1 5-HETE can be generated by both 1 5-LO-dependent and -independent pathways from AA (23, 24) . Since the cDNA sequence for 15-LO has been determined ( 19) , the presence of this transcript was evaluated in HAM. Given the limited cell numbers ( 10-15 X 106 HAM/ BAL) obtained from nonsmokers, RT-PCR was performed utilizing total cellular RNA (see methods). The RT-PCR product was a 300-bp segment of DNA which corresponded to the first 100 amino acids at the amino terminus of the enzyme. Cycle number and the amount oftotal cellular RNA were optimized for both f3-actin and 1 5-LO so that differences in amplified products between samples would be preserved (data not shown). Fig. 2 documents the presence in HAM of an amplified product which corresponds to that expected for 15-LO Peaks for PGE2 and 1 5-HETE were identified by comparison with the retention time for authentic standards and quantities were determined by peak area of "4C dpm on radiochromatograms after correction for recovery of the internal standard (PGB2). Results are expressed as the percent of control represented by parallel incubations carried out in the absence of indomethacin (mean±SEM, n = 3).
mRNA. Peripheral blood monocyte and human lung tissue RNA were used as known negative ( 10) and positive sources of 15-LO mRNA (25) , respectively. The RT-PCR product was digested by Apa-1 and not by Pst-l verifying its origin from 15-LO mRNA and not from 5-LO (Fig. 2) . In the presence of IL-4, the amount of the amplified product was substantially increased.
Since 1 5-HETE can also be produced via cyclooxygenasedependent pathways (23, 24, 26) , we examined the generation of 15-HETE by HAM in the presence ofcyclooxygenase inhibitors: indomethacin (100 ,M) and aspirin (500 ,M). At these concentrations, formation of PGE2 was inhibited while 15-HETE production remained 80.7% (P < 0.04, n = 3) and 102.5% (P = ns, n = 2) of control during incubations in the presence of indomethacin and aspirin, respectively (Fig. 3) . These results indicate that HAM are able to generate 1 either the calcium ionophore (A23187) or FMLP and the products obtained were extracted and characterized. HAM activated by ionophore generated predominantly LTB4 and LTA4 (as monitored by appearance of its non-enzymatic hydrolysis products, 6-trans-and 12-epi-6-trans-LTB4) (Fig. 4) . These chromatograms also revealed materials with the same retention times and electrochemical reactivity as synthetic LXA4 and LXB4 (Fig. 4) . LXA4, LXB4, and LTB4 were also present to some degree when HAM were incubated alone in the absence of stimuli (Table II) . LXB4 levels increased with both A23,87-and FMLP-triggered stimulation as did LTB4; the amounts of both LXA4 and LXB4 were clearly less than those of agonist-induced LTB4 formation. In contrast, LXA4 levels were evident before addition of HAM agonists and did not increase after activation. The ratios of LT to LX production were 0.6, 2.3, and 21.0 with no stimulus, FMLP, or A23187, respectively.
A role for LTA4 in LX generation by HAM. Since 15-LO can convert LTA4 to LX (7, 27) , we examined whether the low levels of LX produced by HAM from endogenous sources could be increased by exposure to LTA4. In the presence of LTA4, HAM generated -2 times more LXA4 and 10 times more LXB4 (Table III) . In these experiments, LTB4 formation also increased 7-fold after LTA4 exposure. Incubation with IL-4 (72 h) did not further enhance HAM production ofLX from LTA4 with either intact or permeabilized HAM using these conditions. Also, IL-4-primed HAM stimulated with A23187 (5 AM, 20 min, 370C) did not generate statistically significant increases in LX levels from endogenous source of substrate above those reported in Table II (data not shown).
Discussion
The present results indicate that HAM possess 1 5-LO activity and can generate 1 5-HETE. 1 5-HETE was identified by several criteria: retention time on RP-HPLC, radiolabeling, and coelution with authentic 15-HETE (Fig. 1) . 15 -LO mRNA was also demonstrated by RT-PCR and selective digestion with a restriction endonuclease of the amplified product (Fig. 2) . Exposure ofHAM to IL-4 selectively increased 15-HETE formation (Table I) and 15-LO mRNA levels (Fig. 2) . In addition, HAM production of 1 5-HETE was reduced by only 20% in the presence ofindomethacin, but was not affected by aspirin (Fig. 3 ). These cells were also able to generate LXB4 from endogenous stores in the presence of stimuli (Fig. 4, Table II ) and both LXA4 and LXB4 when incubated in the presence ofexogenous LTA4 (Table III) . Together these observations are the first to identify 1 5-LO activity in HAM and demonstrate a potential role for these cells in contributing to the formation of the 15-HETE and LX found in BAL fluid (5 , 1 1) .
Several cell types of the respiratory tract can produce 15-HETE including human tracheal epithelial cells, eosinophils, and polymorphonuclear leukocytes (reviewed in reference 23). In the present study, the cell population from freshly obtained BAL fluids represented > 96% HAM, and thus, the 15-HETE identified by physical methods (Fig. 1 ) does not appear to be the result of contaminating cells. The presence of 1 5-LO activity and its induction in HAM may be relevant in humans, since 1 5-LO-derived products display actions in experimental models involving the respiratory tract (4). 15-HETE inhibits vascular cyclooxygenase (23), diverts LT production, and regulates signal transduction after esterification into membrane phospholipids from where it can be released upon subsequent cell activation and serve to "prime" the cell membrane (28). 1 5-HETE is a major eicosanoid in lung tissues (5, 6) and levels of both 15-HETE, identified by gas chromatography/mass spectrometry, and 15-LO mRNA, identified by RT-PCR, increase in BAL fluid from asthmatics after antigen challenge (5, 25, 29) . Since HAM are the predominant cell type in BAL fluid and possess 15-LO mRNA, they are a likely source of 1 5-LO transcription. Thus, HAM have the potential to contribute to 1 5-HETE production in lung tissues. In addition to 15-LO, 15-HETE can be generated by cyclooxygenase-dependent pathways in endothelial (23) and epithelial cells (24) . Recently, isozymes of PGH synthase were identified whose ability to generate 1 5-HETE is enhanced by aspirin and inhibited by indomethacin (24, 26) . The data shown in Fig. 3 however, these cells can also convert AA into 1 5-HETE by an indomethacin-sensitive PGH synthase.
We found that the 1 5-LO activity present in HAM is upregulated after IL-4 treatment (Table I) ; our observation extends the previous demonstration of 1 5 -LO induction by IL-4 in peripheral blood monocytes (10), known precursors of HAM. High levels of IL-4 are present in asthmatic lungs secondary to elaboration by the TH2 subset of T-helper lymphocytes and mast cells (8) . It follows that 1 5-HETE generation by HAM exposed to IL-4 may represent a critical aspect ofcell-cell interactions during immune responses in the lung.
It has been previously shown that LXA4 is detected in BAL fluids from patients with respiratory diseases (11) ; the cell types involved in LX formation in the lung are not known. Formation of LX by activated HAM (Fig. 4 (30) . In support of this biosynthetic origin, LX formation is increased when HAM are incubated in the presence of LTA4 (Table III) . Utilization of extracellular LTA4 by HAM may be an important biosynthetic route for LX, as multiple cell types found in the lung such as mast cells (31) , cytokine-primed neutrophils ( 16) , and macrophages themselves (as monitored in the present study by detection of LTA4-derived nonenzymatic hydrolysis products; Table II ) are capable of releasing LTA4 into the extracellular milieu. In addition, 1 5-LO can also provide 1 5-HETE to 5-LO for further conversion to LX. Recently, HAM were reported to generate prodigious amounts of LX (32) via the transcellular metabolism of exogenous 15-HETE similar to previous observations with human neutrophils (7) . In this regard, airway epithelial cells display high levels of 1 5-LO activity (7, 21 ) . Since LXA4 was detected in HAM prior to the addition of agonists, it is possible that the mechanical agitation of bronchoscopy may have triggered LXA4 and to some extent LXB4 formation present in the in vitro incubations (Table II) . Thus HAM could participate in the generation of lipoxins via at least two routes: ( 1 ) sequential 1 5-LO (donated 1 5-HETE) followed by 5-LO of HAM, or (2) by transformation of exogenous LTA4 by 1 5-LO of HAM. Although LXA4 levels were not increased by typical HAM ago-nists (FMLP and A23187), LXB4 formation was clearly increased (Table II) . Together with the finding that LTA4 increases LXB4 formation (10 times), it appears that HAM possess a LXB4 synthetase (Table III) . Macrophages from other species, such as the rainbow trout, generate microgram amounts of LX from endogenous sources of substrate (33) , indicating that the lipoxin structure has a long evolutionary history and suggesting that its formation in humans may mark a basic functional role of these eicosanoids.
Because there are large numbers ofHAM in alveoli and LX possess modulatory actions in experimental models at concentrations in the range of those reported in Table III , the participation of HAM in the formation of LX in the lung may be relevant in humans. For example, LXA4 antagonizes LTC4-induced contraction of human bronchi (13) and bronchoconstriction of asthmatic human airways ( 14) . LXA4 also inhibits LTB4-induced inflammation (34) and down-regulates LTB4 receptors on lymphocytes (35) . The role of LXB4 in the lung remains to be fully appreciated; however, LXB4 has been demonstrated in submicromolar amounts to inhibit both LTB4-and FMLP-stimulated neutrophil chemotaxis (36), stimulate myelopoiesis (37) , and exert a radioprotective effect in vitro (38) .
In conclusion, HAM possess 1 5-LO activity and can participate in the biosynthesis ofboth 1 5-HETE and LX in the respiratory tract. Furthermore, the production ofthese compounds by HAM can be enhanced by cytokines, such as IL-4, and exogenous substrates, such as LTA4. Cell-cell interactions in the lung may represent important regulatory mechanisms for bioactive eicosanoid formation and action during pulmonary inflammation.
